CL-316,243, a β3-specific adrenoceptor agonist, enhances insulin- stimulated glucose disposal in nonobese rats

Diabetes

Volumn 46, Issue 8, 1997, Pages 1257-1263

  De Souza, Christopher J ^a,b   Hirshman, Michael F ^a   Horton, Edward S ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; DEOXYGLUCOSE; FATTY ACID; GLUCOSE; INSULIN; SODIUM CHLORIDE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030803534     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.8.1257     Document Type: Article

References (42)

1. Arch JRS, Anisworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S: Atypical β-adrenoceptors on brown adipocytes as target for antiobesity drugs. Nature 309:163-165, 1984
2. 3-adrenergic receptor. Mol Pharmacol 40:895-899, 1991
3. 3adrenergic receptor cDNA. FEBS Lett 324:127-130, 1993
4. Muzzin P, Revelli JP, Kuhne F, Gocayne JD, McCombie WR, Venter JG, Giacobino JP, Fraser CM: An adipose tissue-specific β-adrenergic receptor. J Biol Chem 266:24053-24058, 1991
5. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
6. Langin D, Portillo MP, Saulnier-Blanche JS, LaFontan M: Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol 199:291-301, 1991
7. Hollenga C, Haas M, Deinum JT, Zaagsma J: Discrepancies in lipolytic activities induced by β-adrenoceptor agonists in humans and rat adipocytes. Horm Metab Res 22:17-21, 1990
8. Champigny O, Holloway BR, Ricquier D: Regulation of UCP gene expression in brown adipocytes differentiated in primary culture: effects of a new βadrenoceptor agonist. Mol Cell Endocrinol 86:73-82, 1992
9. Milner RE, Wilson S, Arch JRS, Trayhurn A: Acute effects of a β-adrenoceptor agonist (BRL 26830A) on rat brown-adipose-tissue mitochondria. Biochem J 249:759-763, 1988
10. 3 receptors: a promising antidiabetic and antiobesity agent. J Med Chem 35:3081-3084, 1992
11. 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 266:R1371-R1382, 1994
12. Smith SA, Sennitt MV, Cawthorne MA: BRL 35135: an orally active antihyperglycemic agent with weight reducing effects. In New Antidiabetic Drugs. Bailey CJ, Flatt PR, Eds. New York, Smith-Gordon, 1990, p. 177-189
13. Arch JRS, Anisworth AT: Thermogenic and antiobesity activity of a novel βadrenoceptor agonist, BRL26830A in mice and rats. Am J Clin Nutr 38:549-558, 1983
14. 3-adrenoceptor agonist, in mice with monosodium-L-glutamate-induced obesity. Eur J Endocrinol 131:97-102, 1994
15. Assimacopoulos-Jeannet F, Greco-Perotto R, Terrettaz J, Meier MK, Jeanrenaud B: Effect of a β-adrenergic agonist on glucose transport and insulinresponsive glucose transporters (GLUT4) in brown adipose tissue of control and obese fa/fa rats. Pfluger Arch 412:52-58, 1992
16. Smith SA, Levy AL, Sennitt MV, Simpson DL, Cawthorne MA: Effects of BRL 26830: a novel β-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats. Biochem Pharmacol 34:2425-2429, 1985
17. Young P, Cawthorne MA, Smith SA: Brown adipose tissue is a major site of glucose utilization in C57B1/6 ob/ob mice treated with a thermogenic β-adrenoceptor agonist. Biochem Biophys Res Commun 130:241-248, 1985
18. Weir BJ: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9, 1949
19. Hirshman MF, Horton ES: Glyburide increases insulin sensitivity and responsiveness in peripheral tissues of the rat as determined by the glucose clamp technique. Endocrinology 126:2407-2412, 1990
20. Kraegen EW, James DE, Bennett SP, Chisholm DJ: In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol 245:E1-E7, 1983
21. Steele R: Influences of glucose loading and injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
22. Proietto J, Rohner-Jeanrenaud F, lonescu E, Terrettaz J, Sauter JF, Jeanrenaud B: Non-steady-state measurements of glucose turnover in rats by using a one-compartment model. Am J Physiol 252:E77-E84, 1987
23. Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E575-E580, 1985
24. Ferré P, Leturque A, Burnol AF, Penicaud L, Girard J: A method to quantify glu cose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J 228:103-110, 1985
25. Kipnis DM, Cori CF: The penetration and phosphorylation of 2-deoxyglucose in the rat diaphragm. J Biol Chem 234:171-177, 1959
26. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
27. Cawthorne MA, Sennitt MV, Arch JRS, Smith SA: BRL 351135, a potent and selective atypical β-adrenoceptor agonist. Am J Clin Nutr 55:252S-257S, 1992
28. 3-adrenergic receptor agonists in obese mice. Am J Physiol 268:E678-E684, 1995
29. Charon C, Dupuy F, Marie V, Bazin R: Effects of the β-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats. Am J Physiol 268:E1039-E1045, 1995
30. Dolan JA, Muenkel HA, Burns MG, Pellegrino SM, Fraser CM, Pietri Strosberg D, Largis EE, Dutia MD, Bloom JD, Bass AS, Tanikella TK, Cobuzzi A, Lai FM, Claus TH: Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Expt Therap 269:1000-1006, 1994
31. 3-adrenoceptors in obesity. J Clin Invest 95:1109-1116, 1995
32. Himms-Hagen J: Brown adipose tissue thermogenesis and obesity. Prog Lipid Res 28:67-115, 1989
33. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrinol Rev 6:45-86, 1985
34. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36:914-924, 1987
35. Wolf R: Tracers in Metabolic Research. New York, Liss, 1984, p. 98-99
36. Kahn RC, Crettaz M: Insulin receptors and the molecular mechanisms of insulin action. Diabetes Metab Rev 1:5-32, 1985
37. Young P, King L, Cawthorne MA: Increased insulin binding and glucose transport in white adipocytes isolated from C57B1/6 ob/ob mice treated with the thermogenic β-adrenoceptor agonist BRL 26830. Biochem Biophys Res Commun 133:457-461, 1985
38. Rochet N, Tanti JF, Grémeaux B, Van Obberghen E, Le Marchand-Brustel Y: Effects of a thermogenic agent, BRL 26830A on insulin receptors in obese mice. Am J Physiol 255:E101-E109, 1988
39. Le Marchand-Brustel Y, Olichoon-Berthe C, Grémeaux B, Tanti JF, Rochet N, Van Obberghen E: Glucose transporter in insulin sensitive tissues of lean and obese mice: effects of the thermogenic agent BRL 26830A. Endocrinology 127:2687-2695, 1990
40. McCormack J: The regulation of fatty acid synthesis in brown adipose tissue by insulin. Prog Lipid Res 21:195-223, 1982
41. L Nagase I, Yoshida T, Kumamoto K, Umekawa T, Sakane N, Nikami H, Kawada T, Saito M: Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic β3-adrenergic agonist. J Clin Invest 97:2898-2904, 1996
42. Klaus S, Casteilla L, Bouilland F, Ricquier D: The uncoupling protein UCP: a membranous mitochondrial ion carrier exclusively expressed in brown adipose tissue. Int J Biochem 23:791-801, 1991